SynCore Biotechnology Pipeline
| Drug | Indication | Phase |
|---|
| SB01 | Head and Neck Cancer | Phase 2 |
| SB02 | Solid Tumor Anti‑Angiogenesis | Preclinical |
| SB03 | External Genital Warts | Approved |
| SB04 | Age‑Related Macular Degeneration | Phase 2/3 |
| SB05 | Pancreatic Cancer (EndoTAG®‑1) / Triple‑Negative Breast Cancer | Phase 3 |